Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Boletín médico del Hospital Infantil de México
versión impresa ISSN 1665-1146
Resumen
GOITIA-CARDENAS, Mariana; AZOTLA-VILCHIS, Coztli O. y MIRANDA-LORA, América L.. Robinow syndrome and its response to growth hormone treatment. Bol. Med. Hosp. Infant. Mex. [online]. 2023, vol.80, suppl.1, pp.40-46. Epub 11-Sep-2023. ISSN 1665-1146. https://doi.org/10.24875/bmhim.22000101.
Background:
Robinow syndrome is a rare disease with short stature, characteristic phenotypical abnormalities, and intellectual integrity in most cases.
Case report:
We present the case of a 13-year and one-month-old male who came for medical consultation at 3 years of age due to short stature. Additionally, the patient showed craniofacial dysmorphia, congenital heart disease, and growth hormone deficiency. As per family history, the mother presented the same phenotype. The genetic study identified an unreported variant of the WNT5A gene.
Conclusions:
The patient initiated growth hormone treatment at a dose of 0.7 U/kg/week at 4 years of age with favorable results, increasing his height from the < 1st percentile to the 44th percentile.
Palabras llave : Robinow syndrome; Growth hormone; WNT5A gene.